Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Citrate salt of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof

Citrate salt of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof

US Patent 6787549 · Granted Sep 7, 2004

Estimated economic value: $150,240,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrrolo[2,3-d]pyrimidine tosylate salt, crystalline form thereof and manufacturi2024
Crystalline form of lorlatinib free base hydrate2022
Process for forming amorphous atorvastatin2015
Process for forming amorphous atorvastatin2012
Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl2011
Process for the preparation of 1,3-substituted indenes2007
Process for the preparation of 1,3-substituted indenes2007
Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04.9]-hexadeca-2(11),3,5,2007
Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04.9]-hexadeca-2(11),3,5,2007
Pharmaceutically acceptable salts of sertraline and pharmaceutical compositions 2006
Process for preparing naphthyridones and intermediates2006
Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,2005